FOR US HEALTH CARE PROFESSIONALS ONLY
Prescribing Information
APOKYN® (apomorphine hydrochloride injection)GOCOVRI® (amantadine) extended-release capsulesMYOBLOC® (rimabotulinumtoxinB) injectionOXTELLAR XR® (oxcarbazepine) extended-release tabletsQELBREE® (viloxazine extended-release capsules)TROKENDI XR® (topiramate) extended-release capsulesXADAGO® (safinamide) tabletsONAPGOTM (apomorphine hydrochloride), for subcutaneous infusion
Adverse Event/Product Complaint
To report a suspected adverse event or product complaint, contact us at 1-866-398-0833 or email medinfo.supernus@apceris.com.
Connect With Us
Supernus Medical Affairs Logo
FOR US HEALTH CARE PROFESSIONALS ONLY
Supernus Medical Affairs LogoMenu Toggle
FIND AN MSLArrow RightSUBMIT AN INQUIRYArrow Right
Quick Link
QUICK LINKS

FULL LIST OF PUBLICATIONS

Filter icon

FILTER

Sort A-Z

Filter by

Year

2024

Therapeutic Area

Publications ToggleAttention-Deficit/ Hyperactivity Disorder
Publications ToggleParkinson's Disease

Product

Publications ToggleAPOKYN® (apomorphine hydrochloride injection)
Publications ToggleGOCOVRI® (amantadine) extended-release capsules
Publications ToggleQELBREE® (viloxazine)
Publications ToggleONAPGO™ (apomorphine hydrochloride), for subcutaneous infusion

Pipeline

Publications ToggleSPN-817 (Focal onset seizures, including resistant focal onset seizures)
Publications ToggleSPN-820/821 (Treatment-resistant depression)

Phase

Publications TogglePreclinical
Publications TogglePhase 1
Publications TogglePhase 2
Publications TogglePhase 3
Publications TogglePhase 4
Publications TogglePost hoc
Publications ToggleReview

Publications may contain data outside the approved product labeling. Supernus Pharmaceuticals does not support the use of its products in a manner that is not consistent with the product labeling.

Supernus Logo
Research & DevelopmentConnect With UsTerms of UsePrivacy PolicyCookie Policy

This site is intended for US health care professionals.
The content on this website is intended for informational purposes only and should not be used as the sole basis for patient care decisions.

Supernus Pharmaceuticals, Inc.
9715 Key West Avenue, Rockville, MD 20850
(301) 838-2500
info@supernus.com

© 2025 Supernus Pharmaceuticals, Inc.